Egalet to Raise Funds Via Sale of Shares and Warrants

Egalet, a pharmaceutical company, said on Wednesday it is planning to raise funds to market its drugs including morphine sulfate and nasal spray, through the sale of shares and warrants.

The drugmaker said the offering is subject to market conditions, with underwriters granted to sell up to 15% additional shares and warrants of securities sold in the offering. Cantor Fitzgerald is the book-runner.

Leave a Comment